AMBS

AMARANTUS BIOSCIENCE HLDG by Amarantus Bioscience Holdings, Inc. (AMBS)

About AMARANTUS BIOSCIENCE HLDG by Amarantus Bioscience Holdings, Inc. (AMBS)

Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
400
Dividend yield
0.00%
Volume
--
Avg. volume
11
P/E ratio
--

AMARANTUS BIOSCIENCE HLDG by Amarantus Bioscience Holdings, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
400
Dividend yield
0.00%
Volume
--
Avg. volume
11
P/E ratio
--